(S)-(-)-7[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX
CAS:1040274-10-9
Fórmula:
C55H66NOP
Pureza:
98%
Forma y color:
Solid
Peso molecular:
788.0924
Ref: IN-DA008VAU
25mg | 179,00 € | ||
50mg | 342,00 € | ||
100mg | 502,00 € |
Entrega estimada en Estados Unidos, el Lunes 25 de Noviembre de 2024
(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX
CAS:1040274-10-9
(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2,3,3-tetrahydro-1,1-spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX
Fórmula:
C55H66NOP
Pureza:
min. 97%
Forma y color:
white solid
Peso molecular:
788.09
Ref: 08-15-5191
25mg | 125,00 € | ||
100mg | 346,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Diciembre de 2024
(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2,3,3-tetrahydro-1,1-spirobiindane
CAS:1040274-10-9
Please enquire for more information about (S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2,3,3-tetrahydro-1,1-spirobiindane including the price, delivery time and more detailed …
Fórmula:
C55H66NOP
Pureza:
Min. 95%
Peso molecular:
788.09 g/mol
Ref: 3D-QRB27410
100mg | A consultar | ||
250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025